Type 1 Diabetes Virtual Self-management Education and Support

Conditiontype1diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUnity Health Toronto

About this trial

OVERVIEW: People living with type 1 diabetes (T1D) are expected to fit self-management and regular clinical consultations into busy lives. T1D self-management programs that offer frequent contact with care teams are most effective in helping patients achieve optimal glycemic control. However, this is difficult to deliver in the context of current T1D care which involves time-consuming in-person visits during working hours. The proposed study will test a virtual health care intervention to deliver "high frequency, low touch" care aimed at improving metabolic control, while reducing the burden on individuals and their healthcare teams.

STUDY DESIGN: A pragmatic multicenter, open-label, randomized trial to evaluate the short-term effectiveness of a multifaceted virtual health care intervention in improving glycemic control in individuals with T1D. Planned recruitment is 580 participants from 10 specialized T1D centres in Ontario.

INTERVENTION: Our intervention will include 1) frequent, brief virtual visits between patients with T1D and certified diabetes educators (conducted in real time using a secure telemedicine video interface accessible from any PC, tablet or smart phone) combined with automatic appointment reminders, and 2) a centralized web-based platform to provide educational classes, tools, and resources for diabetes self-management. Virtual visits will be an adjunct to routine in-clinic visits for blood pressure monitoring, foot checks, and surveillance for other complications of diabetes. This approach aims to enable patients to receive more education and support than is feasible in traditional health care models, and in a way that is more seamless (i.e. results in fewer disruptions to their daily life) and tailored to their individual needs based on their stage in life.

Eligibility criteria

Qualifiers

Outpatients ≥18 years of age

Physician diagnosis of type 1 diabetes

Currently on an insulin pump or using multiple daily insulin injections.

HbA1c ≥ 7.5% on most recent laboratory report or estimated from CGM/FGM* report, within the last 4 months

Disqualifiers

Diagnosed with non-Type 1 diabetes

Unable to use a computer/tablet or mobile phone

Pregnant

On dialysis

Trial design

Treatments tested in this trial

  • High frequency, low touch virtual health care

Treatment groups

580 Participants
are divided into 2 treatment groups

Locations

9
Waterloo Regional Health NetworkN2G 1G3, KitchenerOntario, Canada
Mackenzie HealthL4C 4Z3, Richmond HillOntario, Canada
Mount Sinai HospitalM5G 1X5, TorontoOntario, Canada
St. Joseph's Health Centre, Unity Health TorontoM6R 1B5, TorontoOntario, Canada

Sponsors and collaborators

Unity Health Toronto

Lead sponsor